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GLOSSARY 
 
1. Apnea: is the cessation of airflow at least 10 seconds. 
2. Apnea index (AI): is the number of apneas per hour of sleep, with 5 or less considered 
normal. 
3. Obstructive sleep apnea (OSA): is the cessation of airflow despite adequate effort to 
breathe. 
4. Central sleep apnea (CSA): is the cessation of airflow from lack of respiratory effort. 
5. Mixed sleep apnea (MSA): is the cessation of airflow starting as central followed by 
obstructive. 
7. Hypopnea (H): is an abnormal reduction of airflow for at least 10 seconds. 
8. Upper airway resistance syndrome (UARS): is an incomplete upper airway 
obstruction without apneas or hypopneas. Snoring, inadequate sleep, and daytime 
sleepiness characterize this condition. 
9. Respiratory disturbance index (RDI): is another term for apnea-hypopnea index 
(AHI). The definition of slight OSA is RDI of 5 to 14 H, moderate OSA is RDI of 15 to 30 
H, and severe OSA is RDI of >30 H. 
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A CRANIOFACIAL MORPHOLOGY STUDY OF PATIENTS WITH 
OBSTRUCTIVE SLEEP APNEA 
 
ABSTRACT  
 
     Obstructive sleep apnea (OSA) is defined as a repetitive cessations of breathing (apneas) 
lasting for at least 10 seconds or more for each event during sleep. The respiratory muscles 
attempt to inspire, but blockages in the upper airway prevent air from reaching the lungs. 
This will cause partial (hypopnea) or complete (apnea) closure of the upper airways with 
consequent adverse effects on sleep quality and gas exchange. The condition affects 
approximately 4% of men and 2% of women in their middle-ages. OSA is a potentially life-
threatening condition in which a patient suffers periodic cessations of breathing during 
sleep.   The aim of this study is to develop a data base on the craniofacial morphology of 
the upper airway morphology and skeletal patterns in patients with OSA and compare the 
findings with those of normal subjects in the control group.  Twenty-five subjects as OSA 
patients and twenty-five as the control group were selected from the Sleep Laboratory by 
using Polysomnography. All the subjects of this study were adults age ranging 18-65 years. 
Methodologies include the measurements of the body mass index (BMI), neck 
circumference, lateral cephalometric X-ray, posterior-anterior X-ray, and upper and lower 
dental study models were taken. For severe OSA cases, the diameter of the pharynx was 
estimated by measuring the length and width of the pharynx at the level of nasopharynx, 
oropharynx, and hypopharynx, and compared with normal subjects by using CT scan. The 
results showed that there was a significant difference in BMI between OSA patients and 
control group (P value=.001), the BMI significantly increased in OSA patients, the neck 
circumference was also increased in OSA patients. The length of soft palate, width of soft 
 xix
palate, width of tongue, upper posterior airway space, middle posterior airway space, lower 
posterior airway space, distance from hyoid bone to mandibular plane, distance from hyoid 
bone to posterior nasal spine, maxillary width, and cranial base flexure angle were statically 
significantly different in OSA patients compared to the control group. There were no 
significant differences between the two study groups in the inter-canine, inter-first and 
second premolar, inter-molar distances of upper and lower arches, maxillary protrusion, 
mandibular prognathism, lower face height, total face height, posterior facial height, facial 
width, mandibular width, anterior cranial base, and posterior cranial base. The CT scan 
shown that severe OSA patients have narrowing of pharynx at the level of nasopharynx, 
oropharynx, and hypopharynx.  In conclusion, craniofacial morphological differences have 
been found in patients suffering from OSA as compared to control, and that a number of 
investigations and measurements are required to detect underlying deformities, to decide 
for the most suitable management methods. 
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Kajian  Morfologi Kranofasial Pesakit- Pesakit Henti Dalam Tidur 
(Bermasalah Tidur Obstruktif Apnea) 
 
ABSTRAK 
Masalah tidur obstruktif apnea (OSA) didefinisikan sebagai pemberhentian pernafasan 
berulang (apneas) yang berlaku sekurang-kurangnya selama sepuluh saat atau lebih pada 
sesuatu ketika semasa tidur.  Otot pernafasan berusaha merangsang tetapi sekatan di 
bahagian  atas saluran pernafasan menghalang  udara dari sampai ke paru-paru. Ini akan 
menyebabkan  penutupan separa atau penuh pada saluran pernafasan bahagian atas yang 
menyebabkan kesan mudarat keatas kualiti tidur dan pertukaran gas. Keaadaan ini memberi 
kesan kepada 4% lelaki dan 2% wanita pada peringkat umur pertengahan.  OSA adalah satu 
keadaan yang membahayakan  nyawa dimana pesakit mengalami pemberhentian  
pernafasan berkala ketika tidur.  Tujuan kajian ini  ialah untuk mengembangkan informasi 
pengkalan data morfologi kraniofasial tentang morfologi saluran pernafasan bahagian atas 
dan corak skeletal dalam pesakit OSA dengan membandingkan  penemuan yang didapati 
dengan keputusan dari subjek yang normal dalam kumpulan kawalan. Oleh itu, dua puluh 
lima orang subjek diambil sebagai  pesakit OSA dan dua puluh lima orang sebagai 
kumpulan kawalan yang dipilih  dari Makmal beradu  menggunakan polysomnografi.  
Semua subjek untuk kajian ini adalah orang dewasa berumur 18 tahun keatas.  
Metodologinya  termasuklah mengira  index jisim badan  (BMI), lilitan leher setiap subjek, 
x-ray cefalometrik lateral, x-ray posterior –anterior, dan model kajian gigi bahagian atas  
dan bawah juga diambil.  Diameter farinks ditentukan dengan mengukur kawasan saluran 
pernafasan yang paling minimal termasuk panjang dan lebar saluran pernafasan pada 
bahagian nasofarink, orofarink dan hypofarink, kemudian dibandingkan dengan subjek 
yang normal menggunakan imbasan CT . Imbasan CT hanya diambil untuk OSA yang 
 xxi
teruk. Usaha juga dilakukan  untuk menentukan kekerapan pesakit untuk tidur dalam situasi 
yang berbeza menggunakan kajiselidik  skala tidur Epsworth. Keputusan menunjukkan 
terdapat perbezaan signifikan BMI antara pesakit OSA  dan kumpulan kawalan (nilai  P = 
.001). BMI meningkat  secara signifikan bagi pesakit  OSA  , lilitan leher pesakit  OSA 
juga meningkat. Panjang lelangit lembut, lebar lelangit lembut, lebar lidah , ruang atas 
posterior saluran udara, ruang tengah posterior saluran udara, ruang bawah posterior, 
saluran udara, jarak antara tulang hioid ke plana madibular, jarak dari tulang hioid ke spina 
hidung, lebar maksilari, dan sudut fleksur  tapak  kranial berbeza secara signifikan bagi 
pesakit  OSA dibandingkan dengan kumpulan kawalan.  Tiada perbezaan  yang signifikan 
antara dua kumpulan kajian dalam inter-kanin, inter-first  dan premolar kedua, jarak inter – 
molar  bahagian  lengkungan atas dan bawah, protusi maksilari, pronatisma mandibular, 
ketinggian muka bawah, ketinggian keseluruhan muka, ketinggian muka posterior, lebar 
muka, lebar mandibular, tapak kranial anterior, dan tapak kranial posterior.  Skala tidur 
Epsworth mempunyai perbezaan yang signifikan bagi pesakit  OSA dan grade skala  
meningkat bagi pesakit OSA.  Imbasan CT menunjukkan bahawa pesakit  OSA peringkat 
teruk mempunyai  farink yang sempit pada  tahap nasofarink, orofarink dan hypofarink. 
Kesimpulannya, kelainan ukuran kraniofasial  telah dikenal pasti dalam pesakit yang 
mengalami OSA, dan beberapa  kajian dan pengukuran lain perlu untuk mengenal pasti 
kelainan yang  berkaitan dan seterusnya menentukan kaedah yang paling sesuai untuk 
menguruskannya. 
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CHAPTER ONE 
INTRODUCTION 
1.1  Background 
     Over the past two decades, medicine and dentistry have increasingly focused on 
breathing disorders during sleep. The characteristics of obstructive apnea have been 
described in the medical and classical literatures for decades, in the 19th century Broadbent, 
who described the perfect silence during sleep through two, three, or four respiratory 
periods in which accompanied by ineffectual chest movements. Finally air enters with a 
loud snort, after which there are several compensatory deep inspiration (Jureyda and 
Shucard, 2004). 
 
      The understanding of sleep-disordered breathing has been evolved over the years. The 
first description of abnormal breathing with polygraphic demonstrations during sleep was 
first reported in France in 1955, in-patient with Pickwickian syndrome. Pickwickians 
patients had combination of obesity, edema, cardiac symptoms, and agitated sleep 
presented abnormal breathing patterns during sleep (Gilleminault and Quo, 2001).   
 
     Sleep apnea owes its name to Greek word apnea, meaning “want to breathe” (Yantis, 
1999).  Sleep apnea is a sleep disordered breathing characterized by repetitive cessation of 
breathing (apneas) lasting for at least 10 seconds, and occurring 30 times or more during 7 
hours of nocturnal sleep (DePonte et al., 1999). 
     Partial obstructive of the upper airway, termed hypopneas, also affects oxygen 
saturation, which led to sleep disturbances. These partial obstructions are defined as 
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polygraphic events with a reduction of airflow, as measured by thermistor, also lasting 
more than two breaths. 
 
     Investigations using specific polygraphic recordings of normal-weight patients with 
abnormal breathing during sleep led to the description of the (obstructive sleep apnea) 
OSA. The definition of the apnea syndrome came from studies that coxexist with excessive 
daytime sleepiness or related problems in daytime functions (Guilleminault and Quo, 
2001). 
 
     The discovery of sleep apnea and its various forms and the subsequent elucidation of 
sleep disorder breathing (SDB) as a major mechanism of sleep pathology became a major 
impetus for the development of modern sleep medicine. The discovery obstructive sleep 
apnea (OSA) stimulated vigorous investigations in a new field of respiratory physiology 
focused on the control of upper airway function awake and in sleep (Nowara, 2001). 
 
      Sleep apnea is generally classified into obstructive sleep apnea (OSA), central sleep 
apnea (CSA) and mixed sleep apnea (MSA). OSA was recognized as the most common 
disorder with significant morbidity and potential mortality occurring in 2-4% of middle-
aged adults. It was characterized by recurrent episodes of partial or complete upper airway 
obstruction during sleep. These manifest as a decrease in airflow despite ongoing 
inspiratory efforts. The lack of adequate alveolar ventilation results in oxygen desaturation 
of at least 3%. Sleep-related obstructive breathing events are characterized by transient (10 
seconds or longer) reduction in (hypopnea) or complete cessation of (apnea) respiratory 
flow. OSA is associated to snoring, obesity, systemic or pulmonary hypertension sleep 
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related cardiac dysrhythmias, nocturnal angina, gastroesophageal reflex, impaired quality of 
life, and insomnia.  
 
     CSA, it is less common which caused by some problems in the central nervous system 
and occur when the brain fail to send appropriate signals to the breathing muscle to initiate 
breathing causing cessation of all respiratory effort during sleep (Walter and Eliot, 2002).  
 
      MSA is the combination of both OSA and CSA. An episode of MSA usually starts with 
a central component and then becomes finally obstructive in nature (Jonas 2001). 
 
      Apnea refers to cessation of nasal and oral airflow. Hypopnea refers to a reduction in 
airflow to <50% of baseline in association with oxyhaemoglobin desaturation. Apnea – 
Hypopnea index (AHI) indicating the number of respiratory irregularities per sleep hour. 
AHI is calculated as (total number of apneas + hypopnoea) / (Total sleep time in minutes) 
x60 Obstructive sleep apnea may be mild (AHI < 15 events per hour), moderate (AHI = 15-
30 events per hour), and sever (AHI = >30 events per hour).  
 
1.2 Statement of the problem 
     OSA is a potentially life-threatening condition in the patient, who suffers periodic 
cessation of breathing during sleep, which impairs the quality of life (Ang et al., 2004). 
 
      Sleep apnea patients appear to have at least twice as much hypertension, ischemic heart 
disease and cerebrovascular disease. The most serious potential consequence of sleepiness 
 4
is impaired preferences at the wheel while driving and there is convincing evidence that 
sleepiness is substantial risk factor for driving accidents (McNicholas et al., 2002). 
 
     The National Traffic Safety Administration (NHTSA) estimated that the annual cost of 
motor vehicle accidents related to sleep deprivation totaled $12.4 billion. Other studies 
have shown that patients with sleep-disordered breathing who had been diagnosed with 
sleep apnea can have a seven- to 15-fold increase in accident frequency and an eightfold 
increase in the fault frequency (Bailey and Attanasio, 2001). 
 
      It is reported that 40 to 30 million Americans have some type of chronic sleep 
disturbance, and 20 to 30 million have intermittent sleep–related problem. A survey by the 
Gallup organization indicated that as many as 65 million Americans have sleep disorders 
and that 32% of the 65 million reported excessive daytime sleepiness that can interfere with 
their normal daytime routine (Bailey and Attanasio, 2001).  
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OBJECTIVES OF THE STUDY 
 
3.1 General objective 
The aim of this study is to obtain data base information of the craniofacial deformities in 
patients with obstructive sleep apnea.  
 
3.2 Specific objective 
1. To compare the dental morphometric data between OSA patients and a control group.  
2. To compare the skeletal patterns observed in OSA patients and control group. 
3. To compare the difference of the soft tissue patterns between OSA patients and control 
group. 
4. To compare the length and width of the pharynx between OSA patients and control 
group at the levels of the nasopharynx, oropharynx, and hypopharynx. 
 
3.3 Hypothesis 
Abnormalities of craniofacial structure, including skeletal pattern and upper airway 
morphology, cause obstructive sleep apnea. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Introduction 
       Obstructive sleep apnea (OSA) is the periodic reduction (hypopnea) or cessation 
(apnea) of breathing due to narrowing of the upper airways during sleep. The main 
symptom is daytime sleepiness, which may lead to premature death, hypertension, ischemic 
heart disease, stroke, and road traffic accidents. The high prevalence of the syndrome and 
the morbidity and mortality thought to be associated with it have led to the view that sleep 
apnea may be as big a public health hazard as smoking (Wright et al., 1997). 
 
      The interaction between anatomy and muscle function of the upper airway is 
considerable importance to understanding the OSA (Ono et al., 1996). The 
pathophysiologic etiology of OSA includes factors related to the upper airway, especially at 
the level of the soft palate and the base of the tongue. Other etiologies include, relative 
mandibular retrognathia, low position of the hyoid bone, decrease in posterior airway 
space, increased tongue volume, and enlargement of the palatine or adenoidal tissue 
(Gavish et al., 2000). 
 
     Sleep arousal is an important defense mechanism, which was induced by internal stimuli 
activation of the autonomic nervous system, also called subcortical arousals, which are 
reflected by abrupt cardiac changes such as heart rate, arterial blood pressure, respiratory 
change, muscular or galvanic skin responses. The mechanoreceptor-triggered arousal 
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depends on the level of negative pressure during aggravated inspiration (Scholle and 
Zwacka, 2001). 
 
      The severity of sleep apnea is defined on the basis of the apnea – hypopnea index 
(AHI). OSA is defined by the presence of at least 5 obstructive apneas or hypopneas, or 
both happened per hour while the patient is a sleep. OSA is commonly divided into 3 levels 
of severity: mild AHI < 15 events per hour, moderate AHI are about 15-30 events per hour, 
and sever AHI >30 events per hour.  
 
      Recently, a survey of health care utilization among OSA patients showed that during 
the 10 years before diagnosis they had already been heavy users of health services for 
several years. The estimated cost of this care was twice as much as that of average patients. 
This finding reflected the underlying risk factors such as obesity, alcohol and tobacco 
consumption in OSA patients (Tangugsorn et al., 2001).  
 
     The prevalence of OSA was 4% in men and 2% in women 30 to 60 years of age, and it 
may be much higher among elderly persons. A recent publication from The National Center 
on Sleep Disorders Research at the National Heart, Lung, and Blood Institute suggested 
that sleep apnea is common as asthma (Millman, 1999).  
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2.2 Sleep Apnea 
     Sleep apnea is defined as a repetitive cessation of breathing (apneas) lasting for at least 
10 seconds, and occurring 30 times or more during 7 hours of nocturnal sleep (Francesco, 
1999). 
 
      Sleep apnea is a potentially life-threatening condition in which the patient suffers 
periodic cessations of breathing during sleep, which impairs the quality of life. The main 
presentation is loud snoring which the individual is usually not aware, the irregular 
breathing patterns and restless movements in bed characterize of this disorder. 
 
     The sleep apnea syndrome represents something of a paradox in clinical medicine. On 
the one hand, this disorder has been recognized only in recent decades, and it is still 
regarded as a niche interest by many clinicians, particularly those from clinical disciplines 
other than respiratory medicine, neurology and otolaryngology. On the other hand, the 
syndrome is now recognized as being very common and current epidemiological data 
indicate that sleep apnea syndrome is second only to asthma in the prevalence league table 
of chronic respiratory disorders. Further more, there is increasing evidence that the sleep 
apnea syndrome is associated with a considerable number of adverse sequel in both 
behavioral and physical condition. Behavioral consequences include daytime sleepiness, 
impaired concentration and neuropsychological dysfunction, where as physical 
consequences include cardiovascular disorders, particularly hypertension (McNicholas et 
al., 2002). 
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2.3. Classification of Sleep Apnea 
2.3.1 Obstructive Sleep Apnea 
      Obstructive sleep apnea (OSA) is characterized by repetitive upper airway obstruction 
and increased upper airway resistance, leading to high negative intrathoracic pressure with 
consequent increased work of breathing, alveolar hypoventilation with hypoxemia, 
abnormal autonomic function, frequent arousal, movement of the legs or body, sleep 
fragmentation and derangement of sleep architecture (Lin et al., 2003).  
 
      OSA is a common disorder affecting approximately 4% of men and 2% of women in 
the middle-aged workforce. Snoring is a precursor to OSA, which is more common 
affecting 40-60% of adults. These disorders result from sleep-related narrowing of the 
upper airway, which is though to be to varying combinations of anatomical and 
neuromuscular factors that culminate in an imbalance of forces acting on the airway. The 
respiratory muscles attempt to inspire, but a blockage in the upper airway prevents air from 
reaching to the lung (Figure 2.1). The figure show stop of nasal flow while the muscles of 
thorax and abdomen continue attempt to breath, also it show decrease in oxygen saturation. 
This will causes partial (hypopnea) or complete (apnea) closure of the upper airway, with 
consequent adverse effects on sleep quality and gas exchange. 
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     OSA is an important widely prevalent public health problem. The typical symptoms 
during sleep are apnea, snoring, dyspnea, and choking episodes. Once apnea or hypopnea 
develops, recurrent arousal causes excessive sleepiness and cognitive decreases during the 
daytime. The combination of acute and chronic haemondynamic effects in obstructive sleep 
apnea have been associated with increased risk of myocardial infarction, cerebrovascular 
accidents, hypertension, and congestive heart failure.    
 
 
 
Figure 2.1 Graph showing the attempt of the respiratory 
muscles to breath (Adapted from sleep science laboratory, 
Hospital Universiti Sains Malaysia) 
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2.3.2 Central Sleep Apnea (CSA) 
      Central apnea is defined as 10 seconds or more of no airflow without ventilatory effort 
(Figure 2.2). The figure show stop of nasal flow and the muscles of the thorax and 
abdomen also do not attempt to breath. Central sleep apnea (CSA) is diagnosed if the 
frequency of central apneas and hypopneas exceed 5 per hour and is accompanied by 
symptoms of daytime sleepiness. CSA is thought to develop when a stimulus by 
hypoxemia, arousals, and pulmonary congestion results in periods of increased ventilation 
and subsequent decline in CO2 (Hahn and Staats, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     CSA constitutes a heterogeneous group of disorders whose common feature is a 
momentary cessation of breathing during sleep due to a transient withdrawal of central 
Figure 2.2 Graph showing no attempt of respiratory muscles to 
breath(Adapted from sleep science laboratory, Hospital Universiti 
Sains Malaysia) 
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respiratory drive to the muscles of respiration. Thus, in contrast to OSAS, in which 
respiratory drive continues during apnea, in CSA no respiratory efforts or intrathoracic 
pressure swings are generated.  
 
     The clinical evaluation and treatment of these disorders is challenging because they are 
relatively uncommon, which can arise from entirely different underlying causes, and have 
widely varying clinical presentations. Increases in CO2 generally result from reductions in 
ventilation or outright apneas due to an underlying depression of respiratory drive (Walter 
and Eliot, 2002). 
 
      The CSA patient’s having a loss of oxygen to the lung caused by the respiratory chest 
muscles make no attempt to breath as a result of central nervous system disorder. In 
patients with idiopathic central hypoventilation, pulmonary function test results typically 
are normal, unless there is coexisting lung disease, and tests of respiratory strength also are 
normal. The apnea and hypopnea that occur in association with central hypoventilation 
syndrome, the central feature of sleep hypoventilation is an abnormal increase in CO2 
during sleep (Walter and Eliot, 2002). 
 
     Since no airway obstruction is present in CSA, it seems that central and peripheral 
chemoreceptors play a more prominent role. It is generally accepted that the rapidly 
responding peripheral chemoreceptors are the most likely cause of feed-related respiratory 
instability (Verbraecken et al., 1998). 
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2.3.3 Mixed sleep apnea (MSA) 
     MSA is due to an absent ventilatory effort (a ‘central’ pattern), and subsequently persists 
despite resumption of ventilatory efforts (an ‘obstructive’ pattern).  
 
     Central apneas can predispose to obstructive apneas. During central apnea, the central 
drive to the respiratory muscles is withdrawn and airflow ceases, thus the anatomically 
predisposed pharyngeal airway becomes compliant and is susceptible to collapse during the 
subsequent inspiration (Hahn and Staats, 2004).   
 
     Patients with OSA who also have prolonged central apnea should undergo imaging 
studies of the brainstem, most accurately performed by magnetic resonance imaging. 
Particular attention should be directed to the brainstem and cervico-medullary junction for 
evidence of a Chiari malformation or space-occupying lesion (Kirk et al., 1998). 
 
     Mixed apneas contain polysomnographic characteristics consistent with a central and 
obstructive component. There is evidence, however, that the central compound of a mixed 
apnea is actually a prolongation of exhalation against an obstructed upper airway or a brief 
expiratory apnea before the resumption of cyclic respiratory efforts. 
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2.4 Hypopnea 
     Hypopnea is defined as an event which is characterized by disproportionate reduction of 
inspiratory airflow relative to inspiratory effort or metabolic needs. The American 
Academy of Sleep Medicine Task Force defined or characterized hypopnea as follows:’ A 
clear decrease (>50%) from baseline in the amplitude of a valid measure of breathing 
during sleep or an amplitude reduction (<50%) associated with either an oxyhemoglobin 
desaturation (>3%) or an arousal, and the event should last at least 10 seconds. Hypopneas, 
like apneas, can be central or obstructive, although this distinction is infrequently made 
when reporting clinical sleep studies (Jonas et al., 2001). 
 
     Gould et al. (1987) have observed a number of patients with full clinical picture of the 
obstructive sleep apnea syndrome who have had no apnea at all but instead have had 
recurrent episodes of nocturnal hypoventilation. In the absence of apneas, these patients 
cannot be said to have the sleep apnea syndrome, which was originally defined purely in 
terms of nocturnal apnea frequency. Further confusion is caused by disagreement as to the 
definition of a hypopnoea, some describing them as a decrease in the airflow signal, some 
as a decrease in thoracoabdominal movement, and others as a decrease in the airflow in 
association with 4% drop in oxygen saturation.   
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 2.5 Apnea, Hypopnea, and Apnea + Hypopnea Indices 
     Dividing the total number of apneas during a recording period by the total sleep time 
yields the average number of apneas per hour of sleep, or apnea index (AI). Similarly a 
variety of other indices, including hypopnea index (HI) and apnea + hypopnea index (AHI) 
(also termed the respiratory disturbance index RDI)) are usually employed to quantify 
OSAS severity. The concept of ‘index’ permits standardization of event frequency for the 
number of hours slept. This facilitates the comparison of individual patient data with 
normative as well as pre- and post – treatment values (Jonas et al., 2001). 
 
     Alternatively, the AHI can be considered similar to blood pressure, with increasing 
values indicative of increasing disease severity. The advantages of using the AHI to 
classify disease status include its relative simplicity and high night-to-night reproducibility. 
The disadvantages of using AHI as a sole indicator of disease include the between-
laboratory variability in measurement technique, its lack of informativeness regarding the 
severity of individual events (duration, associated hypoxemia and arousal) and its 
uninformativeness regarding the functional and physiological impact of the disorder 
(Redline and Tishler, 2000).   
 
2.6 Upper Airway Resistance Syndrome 
     The upper airway resistance syndrome (UARS) is defined by repetitive and 
progressively increasing inspiratory efforts with subsequent transient arousals, but without 
associated reduction in airflow (Jonas et al., 2001). Bader (2000), described the 
combination of habitual heavy snoring, increased upper-airway resistance, sleep 
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fragmentation, and daytime sleepiness is referred to as the upper-airway resistance 
syndrome. 
 
     Patients with UARS will go to sleep, then begin loud, crescendo snoring which leads to 
an arousal or awakening. This arousal is followed by the patient’s falling back to sleep, 
resumption of snoring, and awakening again. These patients may exhibit all the clinical 
symptoms of OSA but without apneic or hypopneic events. Upper airway resistance 
syndrome is not a well-defined condition, and its diagnosis is therefore difficult. These 
patients are presently treated if they had OSA. 
 
     Patients with OSAS and UARS complain of day time tiredness, fatigue, and variable 
degrees of sleepiness. There was no difference in daytime sleepiness and daytime tiredness 
between the OSAS and UARS. Several hypotheses may be proposed to explain the 
differences in sleep electroencephalogram activity seen in OSAS and UARS patients. The 
differences suggest that both groups of patients have different cortical responses to 
abnormal respiratory challenges during sleep. There may be a different integration of 
messages from the periphery (i.e. respiratory apparatus) in the central nervous system 
(Gilleminault et al., 2001). There are indications that the microstructure of nocturnal sleep 
is different in UARS and OSAS, and patients with OSAS present more important drops in 
oxygen saturation with their abnormal breathing events than UARS patients. But further 
research is needed to understand the exact relationship between the two clinical entities 
(Gilleminault et al., 2000). 
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     During nasal breathing the nasal passages constitute a relevant upstream inspiratory 
resistor whereas during mouth breathing the oral cavity is the potential site of upstream 
resistance. The resistance to airflow through the oral cavity is a major component of total 
upper airway resistance during oral and oronasal breathing. Mouth breathing occurs during 
sleep, even in normal subjects, and may be increased during sleep disordered breathing 
events (Lin et al., 2003).   
 
2.7 Upper Airway Anatomy 
     The anatomy of the upper airway, including the oral cavity, begins with intake of air 
through either the nose or the mouth. The critical component controlling the airway 
function are the muscles that control airway dimension or opening and are related to the 
primary structures of the airway, such as the tongue, soft palate, and uvula as well as the 
upper and lower pharynx. Some hard structures need to be considered, especially within the 
nose (Bailey, 2001).    
 
     The upper airway is generally divided into three regions based on midsagittal anatomy. 
These regions are first, the nasopharynx (the nasal turbinates to the hard palate). Second, 
the oropharynx, which is subdivided into a. retropalatal (the level of the hard palate to the 
caudal margin of the soft palate) and b. the retroglossal (the caudal margin of the soft palate 
to the base of the epiglottis) regions; and third, the hypopharynx, (the base of the tongue to 
the larynx) (Figure 2.3) (Schwab, 2001). 
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     Upper airway dilator muscles play an important role in the determining the upper airway 
collapsibility. The dilating force developed by these muscles is only one that 
counterbalances the collapsing forces represented by the negative transmurul pharyngeal 
pressure and by the weight of upper airway structures. 
 
     At the pharyngeal level there is no bony or cartilaginous structure on maintain the 
aperture of the upper airway. Therefore, the maintenance of upper airway patency depends 
on the force developed by the contraction of upper airway dilators (Series, 2002). The 
pharynx extends superoinferiorly from the base of the cranium to the level of the inferior 
surface of the body of the 6th cervical vertebra. The pharynx lies dorsal to the nasal cavity, 
the oral cavity, and the larynx. 
 
     The contraction of the diaphragm against the high resistance offered by the nose during 
inspiration creates a subatmospheric intra-airway pressure which may narrow the 
collapsible pharyngeal segments in the pharynx. There are three collapsible pharyngeal 
segment which include the retropalatal pharynx as a velo- or nasopharynx, posterior to the 
soft palate, the retroglossal pharynx where oropharynx, posterior to the tongue from the tip 
of the uvula to the tip of the epiglottis) and the retroepiglottic pharynx (laryngo- or 
hypopharynx, posterior to the epiglottis). These pharyngeal segments are collapsible 
because the anterior and lateral walls lack bony support. The adult human is the only 
mammal to have an oropharynx (in all other mammals the tip of the uvula touches the tip of 
the epiglottis) and to suffer from OSA (Benumof, 2001). 
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2.8 Normal Physiology of Upper Airway 
     The upper airway is basically a soft tissue tube, the patency of which is maintained in 
part by the activity of muscular groups of which the tensor veli and genioglossus muscles 
are highly important members. The action of these muscle groups has an important 
influence on the physiology of sleep disorders. 
 
     The upper airway is a complex structure with many competing physiological functions, 
including swallowing, speech and breathing. It is richly innervated and its mechanical 
behavior is influenced by a multitude of neural controls and reflexes (Ayappa and 
Rapoport, 2002). 
Figure 2.3 Diagram showing nasopharynx, oropharynx and     
hypopharynx (Adapted from www.dentalresource.com) 
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     According to the “balance of the pressures” concept, the size and the resistance of the 
airway depends on the balance between collapsing intraluminal pressures generated during 
inspiration by subatmospheric pressures in the thorax and outward contraction forces of the 
upper airway dilator muscles. Patency of the airway depends on transmurul pressure (Ptm), 
which is the different between the negative intraluminal pressure caused by inspiratory 
efforts and the positive pressure from the upper airway musculature (Ayappa & Rapoport, 
2002). 
 
     The influence of upper airway compliance on upper airway muscle characteristics can 
be accounted for by the influence of negative airway pressure on the activity of these 
muscles; the more compliant the upper airway tissues, the greater the decrease in the 
pharyngeal cross-sectional area with decreasing upper airway pressure, the greater the 
increase in airflow velocity with decreasing upper airway patency, with a further increase 
transmurul pressure gradient in a self-aggravating phenomenon. Therefore, the maintenance 
of upper airway patency during wakefulness requires a constant adaptation of upper airway 
dilator activity to counterbalance the destabilizing effect of the increase in upper airway 
collapsibility in Sleep apnea / hypopnoea syndrome (SAHS) (Series, 2002).  
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2.9 Pathophysiology of the Upper Airway 
      Anatomic abnormalities of the pharynx are thought to play a role in the pathogenesis of 
obstructive sleep apnea. One key feature of sleep is suppression of upper airway muscle 
activity, and a sleep-related decrease in upper airway dilator muscle force is thought to 
lead pharyngeal narrowing or closure in patients with obstructive sleep apnea or hypopnea 
(Isono et al., 1997).  
 
      There is structural narrowing between either the area behind the soft palate and the 
posterior pharyngeal wall; including the uvula and the tonsils, or the area between the base 
of the tongue the posterior pharyngeal wall, or both sometimes, although not as frequently, 
the hypopharynx is also narrowed. What appears to happen is that the muscles, particularly 
the genioglossus, that keep the airway open in the waking state and are phasic inspiratory 
in nature become somewhat blunted in their response during sleep, allowing a narrowed 
airway to collapse. Then, the increased effort of the chest wall muscles builds up negative 
pressure in the lungs, and an arousal take place to break the cycle (Cartwright, 2001). 
 
      OSA occurs when the dilator muscles of the upper airway (geniohyiod, genioglossus, 
tensor veli palatine) lose their tone and are unable to offset the negative pressure of the 
inspiration which draws the base of tongue (including the epiglottis) and soft palate 
posteriorly against the pharyngeal walls (Friedlander et al., 2000). The inspiratory patency 
of the retropalatal, retroglossal, and retroepiglottic pharynx is caused by contraction of the 
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tensor palatine, the genioglossus, and the hyoid bone muscles, respectively (Benumof, 
2001). 
 
     The pharynx is patent at atmospheric intraluminal pressure in normal subjects, and 
requires negative intraluminal pressure for closure. In contrast, patients with obstructive 
sleep apnea had positive closing pressure, ie, the pharynx was closed at atmospheric 
intraluminal pressure. Hence, the surrounding extraluminal pressure is an important 
contributor to the collapsing transmurul pressure during sleep (Badr et al., 1999).   
      
     Upper-airway dysfunction and the specific sites of narrowing or closure are influenced 
by the underlying neuromuscular tone. Upper-airway size is determined by soft-tissue and 
skeletal factors that are also the major determinants of upper-airway patency during sleep. 
In obese patients, increased adipose tissue in the neck may predispose the airway 
narrowing.  
 
     During sleep the neural impulses to pharyngeal dilator muscle are diminished, allowing 
the anatomical forces to increase pharyngeal collapsibility. Two hypotheses have been 
proposed to explain the maintenance of pharyngeal airway during sleep. The neural 
hypothesis proposes the loss of wakefulness stimulus and diminished neural drive to 
pharyngeal dilator muscles during sleep, promoting the highly compliant pharynx to 
narrow or collapse. The second hypothesis implicates the role of mechanical factors 
inherent in the pharynx as the mechanism of airway collapse (Mohesinin, 2003). 
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      The size of the pharyngeal lumen is determined by balance between outward forces 
developed by active contraction of upper airway muscles and inward forces resulting from 
subatmospheric luminal pressure during inspiration (Isono et al., 1997). The upper airway 
obstructions are classified for purpose of treatment: type I, an upper pharynx obstruction, 
involves the palate, uvula, and tonsils; type III, a lower pharynx obstruction, involves the 
tongue base and supraglottic structures; and type II is a combination of upper and lower 
obstructions (Waite, 1998). 
 
2.9.1 Shape and Position of the Tongue 
     The tongue plays an important role in OSAS, in the supine position the tongue projects 
posteriorly by gravity, only counteracted by the tone of the genioglossal muscle (Figure 
2.4). Herper (1976) and Sauerland (1978) have documented loss of tone in the 
genioglossal muscle during apnoeic periods and suggested that the posterior projection of 
the tongue onto the posterior pharyngeal wall accounts for the obstruction. Both the size 
and position of the tongue are important determinators wherther apnoeic periods are 
precipitated (Lyberg, 1989). 
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     The important role of the tongue in the pathogenesis of OSA has been confirmed in 
several studies. There is evidence that phasic respiratory activity of the phasic 
genioglossus is diminished in patients with OSA. This relaxation of the genioglossus 
during sleep would cause posterior displacement of the tongue, thus further occluding an 
already narrow airway it must be stressed that the genioglossus is only one of the muscles 
that are important in maintaining airway patency. Other muscle, such as the tensor 
palatine, which holds the soft palate up, and the masseter, which prevents the recession and 
rotation of the mandible during sleep, may also play an important role in the pathogenesis 
of OSA (Rivlin et al., 1983).     
Figure 2.4 Abnormal airway during sleep (Adapted from 
American Academy of Family Physion, 1999) 
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      Electromyogram of the genioglossus during sleep has shown decreased activity in 
response to airway occlusion in nine premature infants with mixed obstructive and central 
apnea. A similar study in older children who had OSA secondary to tonsillar hypertrophy 
showed no decrease in genioglossus electromyogram activity at the onset of an obstructed 
breath however, there was an in increase in activity of the electromyogram at the end of the 
obstructive (Singer and Saenger, 1990). 
 
     Enlargement of the tongue as defined by the tongue extending about the level of the 
mandibular occlusal plane was associated with increased risk for OSA when controlled for 
other variables within the model but was not significant after controlling for body mass 
index and neck circumference ( Figure 2.5). Macroglossia is a common feature in 
individuals with Down syndrome and is likely to be a major factor in the increased 
prevalence of obstructive sleep apnea observed in this population. 
 
     There is a trend for patients with sleep disordered breathing to have larger tongue size 
compared with people without sleep disorder breathing, but tongue size is independent of 
AHI. Tongue size positively correlates with body mass index and neck circumference (Do 
et al., 2000).  
 
 
 
